Method of treating migraine headaches with a highly selective noreoinephrine reuptake inhibitor
US6642235B2 · kind B2 · utility
13Cited by
8References
39Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 4, 2002 |
| Grant date | Nov 4, 2003 |
| Priority date | — |
| Expiry date | Jan 31, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods for treating humans suffering from, migraine headaches by inhibiting reuptake of norepinephrine are disclosed. The methods comprise a compound having a pharmacological selectivity of serotonin (Ki)/norepinephrine (Ki) of at least about 5000. Examples of such compounds include reboxetine, and more preferably optically pure (S,S) enantiomer of reboxetine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.